文献速递乳腺MR

新辅助化疗后乳腺MRI新定义「细微背景强化」:微观残留病变的标志物?

Subtle ground enhancement a new definition for breast magnetic resonance imaging (MRI) after neoadjuvant chemotherapy: is it a marker for microscopic residual disease?
PubMed 文献 · Clin Radiol · 2026-03-23

单中心回顾性研究分析332例乳腺癌新辅助化疗后乳腺MRI,定义RECIST未涵盖的「细微背景强化」(SGE)并与病理对照。27例检出SGE,其中16例术后有残留浸润癌;SGE与正常腺体强化比值预测残留肿瘤的最佳截断值为1.595,敏感度87.5%、特异度54.6%。SGE有潜力提高新辅助化疗后MRI评估残留病变的准确性。

要点

  • 新辅助化疗后MRI判读应关注RECIST未涵盖的细微背景强化(SGE)。
  • SGE与周围腺体强化比值≥1.595提示残留浸润癌可能,敏感度高但特异度有限。
  • SGE区域术后病理可无残留癌,需结合临床避免过度判读。

核心结论

  • SGE是新辅助化疗后乳腺MRI的新定义征象,有潜力提高MRI评估残留病变的准确性。

研究设计与样本

  • 单中心回顾性研究,分析新辅助化疗后乳腺MRI,由2名放射科医师按RECIST标准分类。
  • 共332例患者,检出SGE者27例纳入研究组,与术后组织病理学结果对照。
  • SGE定义为新辅助化疗后晚期增强MRI上视觉评估强化程度略高于周围腺体的区域。
  • 采用感兴趣区测量SGE最强化区域与周围邻近腺体的强化比值并计算比值。
  • 以ROC曲线分析确定统计学显著参数的最佳截断值并计算诊断价值及置信区间。

关键影像表现/征象

  • SGE表现为新辅助化疗后晚期增强MRI上强化程度略高于周围腺体的区域,视觉评估可识别。
  • 27例SGE患者术后病理显示16例有残留浸润癌、11例为完全缓解。

诊断标准与关键数值

  • SGE与正常腺体强化比值预测残留肿瘤的最佳截断值为1.595。
  • 以比值1.595为截断值,预测残留肿瘤的敏感度为87.5%(95%CI:68.8%-100%)。
  • 以比值1.595为截断值,预测残留肿瘤的特异度为54.6%(95%CI:27.3%-81.8%)。

临床应用与阅片要点

  • 新辅助化疗后MRI判读RECIST分类之外,应留意晚期增强序列上轻度高于周围腺体的SGE区域。
  • 可测量SGE最强化区与邻近腺体强化比值,比值≥1.595时提示残留浸润癌可能。
  • SGE特异度有限,阳性者需结合临床及多序列信息综合判断,避免过度诊断。

局限性

  • 单中心回顾性研究。
  • SGE病例数有限(27例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: This study aims to describe 'subtle ground enhancement' (SGE) patterns as a new definition and investigate the diagnostic contribution of 'SGE' in magnetic resonance imaging (MRI) evaluation after neoadjuvant chemotherapy (NACT) by correlating with histopathology.

MATERIALS AND METHODS: This is a single-centre retrospective study. Breast MRI examinations after NACT were analysed by 2 radiologists and classified according to the Respond Evaluation Criteria In Solid Tumours (RECIST) criteria. Cases with SGE, which is not included in the RECIST criteria, were the study group. On post-NACT, late-phase contrast-enhanced MRI series, areas that showed slightly more intense enhancement than the surrounding parenchyma with visual assessment were recorded. Measurements were made with region of interests, from the region where the SGE was most intense, and from the surrounding adjacent parenchyma, and ratios were calculated. Receiver operating characteristic curve analysis determined cut-off values according to the statistically significant parameters. The diagnostic values and CIs were obtained.

RESULTS: SGE was detected in 27 of 332 patients. After surgery, histopathological examination revealed residual invasive tumours in 16 of 27 patients with SGE, a complete response in 11 patients. The optimum cut-off value calculated for the ratio of SGE to normal parenchyma was 1.595 showing a sensitivity and specificity at 87.5% (95% CI: 68.8%-100%) and 54.6% (95% CI: 27.3%-81.8%), respectively, in predicting the residual tumour.

CONCLUSION: SGE is a new definition, and our studydespite the limited number of cases showed that this finding has the potential to increase the accuracy of MRI after NACT.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Yılmaz E, Mısır ME, Seker ME, et al. Subtle ground enhancement a new definition for breast magnetic resonance imaging (MRI) after neoadjuvant chemotherapy: is it a marker for microscopic residual disease? Clin Radiol. 2026. PMID: 42025107. doi:10.1016/j.crad.2026.107349

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。